Your browser doesn't support javascript.
loading
Legumain protease-sheddable PEGylated, tuftsin-modified nanoparticles for selective targeting to tumour-associated macrophages.
Liang, De-Sheng; Wen, Zu-Jun; Wang, Jia-Hui; Zhu, Fang-Fang; Guo, Feng; Zhou, Jian-Liang; Xu, Jian-Jun; Zhong, Hai-Jun.
Afiliação
  • Liang DS; School of Pharmacy, Nanchang University, Nanchang, P. R. China.
  • Wen ZJ; School of Pharmacy, Nanchang University, Nanchang, P. R. China.
  • Wang JH; School of Pharmacy, Nanchang University, Nanchang, P. R. China.
  • Zhu FF; School of Pharmacy, Nanchang University, Nanchang, P. R. China.
  • Guo F; School of Pharmacy, Nanchang University, Nanchang, P. R. China.
  • Zhou JL; Department of Cardiovascular Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, P. R. China.
  • Xu JJ; Department of Cardiovascular Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, P. R. China.
  • Zhong HJ; School of Pharmacy, Nanchang University, Nanchang, P. R. China.
J Drug Target ; 30(1): 82-93, 2022 01.
Article em En | MEDLINE | ID: mdl-33775195
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuftsina / Nanopartículas Tipo de estudo: Risk_factors_studies Idioma: En Revista: J Drug Target Assunto da revista: FARMACOLOGIA Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuftsina / Nanopartículas Tipo de estudo: Risk_factors_studies Idioma: En Revista: J Drug Target Assunto da revista: FARMACOLOGIA Ano de publicação: 2022 Tipo de documento: Article